Exorphia

Developer of exosome-based therapeutics for various diseases

placeChiyoda-ku, Tokyo-to, Japan calendar_todayFounded 2019 groups4 employees language exorphia.com

Innovation

3 patent families (1 granted) — focus: Chemistry & metallurgy, Physics & computing, Human necessities; filing pace accelerating. Cited 48 times.

YearFilings
20221
20231
20241
20252
20261

Social engagement

Social engagement: 251 social following, 6 posts in the last 12 months — below the industry typical range.

Investor mix

1 investor on record.

Investor typeCountShare
Venture capital1100%

Recent activity

12 Sep 2025
Event
7th Exosome-Based Therapeutic Development Summit
12 Sep 2025
Event
EXORPHIA20251011()
27 Aug 2025
Event
MSC-EV
Coming soon